|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
5R42CA168107-04
|
$307,237
|
$153,619
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$1,800
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$187,905
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$27,240
|
Fowler, Daniel
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$2,044
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$578
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
|
5R01CA161026-07
|
$373,399
|
$186,700
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$380,715
|
$95,179
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$42,641
|
$2,132
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$836,367
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Smartphone for molecular cancer diagnostic in Africa
|
5UH2CA202637-02
|
$491,375
|
$245,688
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Sleep Apnea in Survivors of Childhood Cancer Treated with Thoracic Radiation (APNEA
|
1R01CA215405-01A1
|
$657,845
|
$657,845
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
SEER, Registries, and Special Projects
|
ZIA CP010131-10560
|
$33,448
|
$3,345
|
Linet, Martha
|
DCEG (NCI)
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-05
|
$393,163
|
$196,582
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$21,000
|
N/A
|
National Institutes of Health
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-04
|
$364,000
|
$120,120
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
Regulation of Exocytosis from Immune Cells
|
ZIA BC 011035
|
$63,001
|
$15,750
|
Roche, Paul
|
CCR (NCI)
|
|
Regulation of EBV Latency by EBNA1
|
5R01CA093606-15
|
$329,956
|
$263,965
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$87,105
|
$17,421
|
Engels, Eric
|
DCEG (NCI)
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$4,983,045
|
$398,644
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and
|
ZIA CP010131-04134
|
$96,661
|
$14,499
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$420,830
|
$84,166
|
Hakim, Frances
|
CCR (NCI)
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$587,118
|
$117,424
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Pooling project of NCI and Cross-Canada studies
|
ZIA CP010119-10649
|
$60,369
|
$12,074
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$492,058
|
$98,412
|
Figg, William
|
CCR (NCI)
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-04
|
$161,608
|
$64,643
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
|
1P01CA214091-01
|
$1,356,357
|
$311,962
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-04
|
$634,404
|
$15,860
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$269,487
|
$21,559
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
Molecularly Targeted Therapy for Lymphoma
|
5K24CA184039-04
|
$172,224
|
$34,445
|
GOPAL, AJAY
|
UNIVERSITY OF WASHINGTON
|
|
Microbial diversity and human malignancy
|
ZIA CP010214-10419
|
$5,049
|
$1,010
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$200,544
|
$20,054
|
Gulley, James
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,201,344
|
$210,067
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$307,515
|
$30,752
|
Levens, David
|
CCR (NCI)
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$486,708
|
$97,342
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$574,502
|
$57,450
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Low dose and low dose-rate cancer risk
|
ZIA CP010132-10681
|
$13,875
|
$2,081
|
Little, Mark
|
DCEG (NCI)
|
|
In Vivo Model of Epstein-Barr Virus Latency
|
5R01CA073507-19
|
$372,677
|
$186,339
|
LONGNECKER, RICHARD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Improving Hospice Use for Patients with Blood Cancers
|
1K08CA218295-01
|
$176,867
|
$44,217
|
ODEJIDE, OREOFE
|
DANA-FARBER CANCER INST
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$2,147,291
|
$322,094
|
Pastan, Ira
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$251,622
|
$25,162
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$420,830
|
$84,166
|
Hakim, Frances
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,095,338
|
$219,068
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
|
ZIA BC 010598
|
$795,872
|
$39,794
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
5R01CA206019-02
|
$816,487
|
$816,487
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$79,288
|
$75,324
|
Goldin, Lynn
|
DCEG (NCI)
|
|
HIV and Cancer
|
ZIA CP010150-10071
|
$90,450
|
$13,567
|
Engels, Eric
|
DCEG (NCI)
|
|
High dose/high dose rate radiobiological and radioepidemiological data
|
ZIA CP010131-10595
|
$8,056
|
$1,208
|
Little, Mark
|
DCEG (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,018,548
|